Dataset opportunity
Medasil — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Medasil, usable for Regulatory RAG and Compliance Copilots.
Score
69.1
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Regulatory Affairs market = $1.31B in 2024, CAGR 18.60%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Partial
Legal
Owned by the company — clean to license
Buyer persona
RegTech & compliance-AI vendors
Medasil holds a Regulatory Records Dataset in Text modality, containing decades of proprietary industrial_data such as manufacturing specifications, quality control records, and historical business_records of its NHS supply chain dating back to 1974. This extensive, real-world textual data is exceptionally well-suited for developing and fine-tuning a Regulatory RAG system, enabling it to accurately answer complex queries on medical device compliance and manufacturing history.
The global AI in Regulatory Affairs market was estimated at $1.31 billion in 2024 and is projected to grow at a 18.60% CAGR, demonstrating immense business value. Despite access complexities due to its proprietary technical specifications for silicone-based devices, the dataset's rarity and depth offer a significant competitive advantage for AI buyers aiming to automate and enhance regulatory compliance in this high-growth sector. ⚠ Diligence (valuable data, access to negotiate): Data is primarily industrial manufacturing and quality control records.; Historical supply chain data for NHS procurement since 1974.; Proprietary technical specifications for silicone-based medical devices. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Medasil possesses a deep, proprietary archive of regulatory and commercial records from decades of medical device manufacturing. This dataset is a rare opportunity for RegTech and compliance-AI vendors to acquire authentic documentation, including materials related to ISO13485 compliance and long-term NHS supply chains. In a rapidly growing AI in Regulatory Affairs market, this data is crucial for building and validating sophisticated RAG models that can navigate real-world compliance pathways.
See dimension details ↓- Dataset Specificity78
dominant 'regulatory', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is driven by the urgent need to automate and enhance compliance within the rapidly expanding AI in Regulatory Affairs market, which is projected to grow at a **18.60% CAGR**.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility50
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility44
low difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License92
ownership=company_owned, licensing=clean
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
surplus=medium — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — Medasil is an ideal target as it's a long-established, family-owned UK SME that manufactures single-use medical devices, a process that inherently generates proprietary regulatory, quality, and production data which it does not appear to be monetizing.
- Deep Qualification90
✓ pass — Medasil is a prime data holder; as a long-standing manufacturer of regulated medical devices since 1974, it inherently produces the exact proprietary manufacturing, quality, and supply chain data specified in the opportunity.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Regulatory records
The evidence points to a repository of regulatory compliance texts, specifically demonstrating adherence to the critical ISO13485 medical device standard, which is essential training data for AI platforms serving the global healthcare industry.
Industrial data
This indicates the existence of manufacturing process data from a controlled Class 8 Cleanroom environment, offering buyers a unique dataset to model the link between production conditions and product quality control.
business_records
The holder possesses decades of commercial documents detailing a long-standing supply relationship with the NHS, providing an invaluable corpus for training AI on the nuances of public sector procurement and healthcare supply chain logistics.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Medasil Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global AI in Regulatory Affairs market = $1.31B in 2024, CAGR 18.60% (source: Grand View Research). Investment score 69.1/100 (confidence 0.49). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Nesslog — Regulatory Records Dataset Opportunity
View opportunity →healthcareHistosonics — Medical Imaging Dataset Opportunity
View opportunity →healthcareQuantadt — Medical Imaging Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read
- Why Buy External Data?3 min read